Effect of iron and retinoic acid on the control of transferrin receptor and ferritin in the human promonocytic cell line U937.
The effect of changes in iron availability and induction of differentiation on transferrin receptor expression and ferritin levels has been examined in the promonocytic cell line U937. Addition of iron (as 200 micrograms/ml saturated transferrin) or retinoic acid (1 microM) both caused approx. 70% reduction in the average number of surface transferrin receptors, while the iron chelator desferrioxamine caused an 84% increase. Comparable changes also occurred in the levels of transferrin receptor mRNA. Neither iron nor retinoic acid significantly altered the half-life of transferrin receptor mRNA in the presence of actinomycin D (approx. 75 min) but a 10-fold increase in stability occurred in the presence of desferrioxamine. Iron and retinoic acid both caused an increase in intracellular ferritin levels (approx. 4-and 3-fold, respectively), while desferrioxamine reduced ferritin levels by approx. two-thirds. The effect of iron and retinoic acid added together did not differ greatly from that of each agent alone. None of the treatments greatly affected levels of L-ferritin mRNA. Virtually no H-ferritin mRNA was detected in U937 cells. These results show that changes in ferritin and transferrin receptor caused by treatment with retinoic acid are similar to those induced by excess iron, and suggest that changes in these proteins during cell differentiation are due to redistribution of intracellular iron into the regulatory pool(s), rather than to iron-independent mechanisms.
Iturralde
M
M
University Department of Bacteriology and Immunology, Western Infirmary, Glasgow, U.K.
Vass
J K
JK
Oria
R
R
Brock
J H
JH
D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D003676:Deferoxamine / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005293:Ferritins / Q000187:drug effects / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007501:Iron / Q000378:metabolism / Q000494:pharmacology*; D009000:Monocytes / Q000166:cytology; D012333:RNA, Messenger / Q000032:analysis; D011990:Receptors, Transferrin / Q000187:drug effects / Q000378:metabolism*; D013234:Stem Cells / Q000378:metabolism; D014168:Transferrin / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology*
D012333:RNA, Messenger; D011990:Receptors, Transferrin; D014168:Transferrin; D014212:Tretinoin; D005293:Ferritins; D007501:Iron; D003676:Deferoxamine; D004121:Dimethyl Sulfoxide